HIMS: From the SPAC Grave to 50% Gains (With More to Come!)
Today, I want to share some exciting updates on one of our portfolio companies: Hims & Hers Health Inc. (NYSE: HIMS). The company just reported earnings and the numbers were fantastic. Its operational momentum is alive and well, and investors pushed HIMS stock higher in response. Our model portfolio now shows an open gain of more than 50% since our August 2022 entry.
Read More